fasting blood glucose


Also found in: Acronyms.

fasting blood glucose

or

fasting plasma glucose

or

fasting blood sugar

(făs′tĭng)
n.
A laboratory test that determines the level of glucose in the blood after an overnight fast, used especially to diagnose diabetes and prediabetes.

fasting blood glucose

; FBG blood glucose level following fasting, i.e. > 14 hours without food; two consecutive FBG recordings of > 6.7 mmol/L is diagnostic of diabetes mellitus (note: some authorities consider that the cut-off point diagnostic of hyperglycaemia is 5.9 mmol/L); see random blood glucose
References in periodicals archive ?
The investigators found that compared to placebo, PCSK9 inhibitors were associated with significant increases in fasting blood glucose of around 2% per year and in HbA1c of approximately 0.
Conclusion: It is concluded that a 25 weeks SSAET program along with routine medical management is more effective treatment in the management of fasting blood glucose level, glycemic control, plasma insulin level and insulin resistance as compared with routine medical management and dietary plan in the management of T2DM.
1% and fasting blood glucose levels compared to placebo.
Triglyceride levels was adversely effected in diabetic patients having high fasting blood glucose.
Weight of the animals (g) and fasting blood glucose (FBG) levels (mg/dl) were recorded on day 1, 7 and 14 of the experiment.
KEY WORDS: Type 2 diabetes; HbA1c%; Fasting blood glucose (FBG); serum zinc; ethnicity; oral hypoglycemics.
The homeostasis model assessment of insulin resistance (HOMA-IR) was calculated using fasting glucose and insulin concentration using the formula; Fasting blood glucose (mg/dl) x fasting insulin (uIU/ml) /40513.
25% at six months, and fasting blood glucose levels decreased from 119 mg/dl to 105 mg/dl.
BOSTON--A prospective cohort study of women with polycystic ovarian syndrome (PCOS) who developed gestational diabetes mellitus during pregnancy has implicated fasting blood glucose, non--high density lipoprotein, and sex hormone--binding globulin as significant predictive factors for the development of GDM.
Clinical studies show that circulating CTRP1 levels are positively correlated with fasting blood glucose levels and homeostatic model assessment-insulin resistance (HOMA-IR) in Chinese patients and nonalcoholic fatty liver patients [11-14].
In its October 2015 recommendation, the USPSTF advocates screening with the hemoglobin Ale, fasting blood glucose, or oral glucose tolerance tests.